Logo image of CEAD

CEA INDUSTRIES INC (CEAD) Stock Fundamental Analysis

NASDAQ:CEAD - Nasdaq - US86887P3091 - Common Stock - Currency: USD

9.5  +0.31 (+3.37%)

Fundamental Rating

2

Overall CEAD gets a fundamental rating of 2 out of 10. We evaluated CEAD against 40 industry peers in the Building Products industry. CEAD has a great financial health rating, but its profitability evaluates not so good. CEAD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CEAD has reported negative net income.
CEAD had a negative operating cash flow in the past year.
CEAD had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CEAD reported negative operating cash flow in multiple years.
CEAD Yearly Net Income VS EBIT VS OCF VS FCFCEAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M

1.2 Ratios

With a Return On Assets value of -27.48%, CEAD is not doing good in the industry: 92.50% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -30.53%, CEAD is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
ROA -27.48%
ROE -30.53%
ROIC N/A
ROA(3y)-39.81%
ROA(5y)-37.82%
ROE(3y)-336.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CEAD Yearly ROA, ROE, ROICCEAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1.3 Margins

CEAD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CEAD Yearly Profit, Operating, Gross MarginsCEAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

More info and screens

8

2. Health

2.1 Basic Checks

CEAD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CEAD has been reduced compared to 1 year ago.
Compared to 5 years ago, CEAD has less shares outstanding
There is no outstanding debt for CEAD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CEAD Yearly Shares OutstandingCEAD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
CEAD Yearly Total Debt VS Total AssetsCEAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

CEAD has an Altman-Z score of -0.45. This is a bad value and indicates that CEAD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.45, CEAD is doing worse than 95.00% of the companies in the same industry.
There is no outstanding debt for CEAD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.45
ROIC/WACCN/A
WACC10.66%
CEAD Yearly LT Debt VS Equity VS FCFCEAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

CEAD has a Current Ratio of 11.42. This indicates that CEAD is financially healthy and has no problem in meeting its short term obligations.
CEAD has a better Current ratio (11.42) than 97.50% of its industry peers.
CEAD has a Quick Ratio of 11.40. This indicates that CEAD is financially healthy and has no problem in meeting its short term obligations.
CEAD's Quick ratio of 11.40 is amongst the best of the industry. CEAD outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 11.42
Quick Ratio 11.4
CEAD Yearly Current Assets VS Current LiabilitesCEAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CEAD have decreased strongly by -196.09% in the last year.
The Revenue for CEAD has decreased by -67.50% in the past year. This is quite bad
The Revenue has been decreasing by -6.32% on average over the past years.
EPS 1Y (TTM)-196.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.21%
Revenue 1Y (TTM)-67.5%
Revenue growth 3Y-6.7%
Revenue growth 5Y-6.32%
Sales Q2Q%-57.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CEAD Yearly Revenue VS EstimatesCEAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CEAD Yearly EPS VS EstimatesCEAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CEAD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CEAD Price Earnings VS Forward Price EarningsCEAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CEAD Per share dataCEAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CEAD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEA INDUSTRIES INC

NASDAQ:CEAD (3/7/2025, 8:11:36 PM)

9.5

+0.31 (+3.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-26 2025-03-26
Inst Owners4.07%
Inst Owner Change77.63%
Ins Owners15.12%
Ins Owner Change15.69%
Market Cap7.60M
AnalystsN/A
Price TargetN/A
Short Float %1.29%
Short Ratio0.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.88
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-4.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.81
FCFYN/A
OCF(TTM)-3.81
OCFYN/A
SpS3.3
BVpS12.75
TBVpS12.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.48%
ROE -30.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-39.81%
ROA(5y)-37.82%
ROE(3y)-336.66%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.42
Quick Ratio 11.4
Altman-Z -0.45
F-Score2
WACC10.66%
ROIC/WACCN/A
Cap/Depr(3y)66.67%
Cap/Depr(5y)41.67%
Cap/Sales(3y)0.26%
Cap/Sales(5y)0.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-196.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-67.5%
Revenue growth 3Y-6.7%
Revenue growth 5Y-6.32%
Sales Q2Q%-57.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.16%
OCF growth 3YN/A
OCF growth 5YN/A